Navigation Links
Blame it on the astrocytes
Date:7/11/2014

evelopment and repair, modulates other components responsible for normal brain function. In this study, the authors were able to show that TGF β1 triggers N-methyl-D-aspartate receptor (NMDA), a molecule controlling memory formation and maintenance through synaptic plasticity. In the study, the group also shows that TGF β1-induction of inhibitory synapses depends on activation of another molecule - Ca2+/calmodulin-dependent protein kinase II (CaMK2)-, which works as a mediator for learning and memory. "Our study is the first to associate this complex pathway of molecules, of which TGF β1 seems to be a key player, to astrocytes' ability to modulate inhibitory synapses", says Flvia Gomes.

The idea that the balance between excitatory and inhibitory inputs depends on astrocyte signals gains strong support with this new study and suggests a pivotal role for astrocytes in the development of neurological disorders involving impaired inhibitory synapse transmission. Knowing the players and mechanisms underlying inhibitory synapses may improve our understanding of synaptic plasticity and cognitive processes and may help develop new drugs for treating these diseases.


'/>"/>

Contact: Flávia Gomes
fgomes@icb.ufrj.br
55-219-980-22770
Publicase Comunicao Cientfica
Source:Eurekalert

Page: 1 2

Related biology news :

1. Sick from stress? Blame your mom… and epigenetics
2. Viruses not to blame for chronic fatigue syndrome after all
3. Scientists conclude high fructose corn syrup should not be blamed for obesity
4. Gene sequencing project finds new mutations to blame for a majority of brain tumor subtype
5. Blame your parents for bunion woes
6. Rainfall to blame for decline in Arctic peregrines
7. Wetlands likely to blame for greenhouse gas increases: Study
8. History to blame for slow crop taming: Study
9. Climate not to blame for the disappearance of large mammals
10. Astrocytes control the generation of new neurons from neural stem cells
11. Who reprograms rat astrocytes into neurons?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... PUNE, India , August 26, 2015 ... (Two, Three, Four, and Five Factor), Application (Travel & ... and Geography - Global Forecast to 2020", published by ... 9.60 Billion by 2020, growing at a CAGR of ... 71 Tables and 82 F igures spread through ...
(Date:8/20/2015)... , Aug. 20, 2015 The ... consumers that are active and healthy. However, wearable ... the hospital environment to help improve diagnostic capabilities ... video from the Wearable Technologies Conference 2015 ... new applications for wearables in healthcare.    ...
(Date:8/18/2015)... Aug. 18, 2015  Navitas today announced ... to the Submission Content Management webinar scheduled ... non-profit forum. Dedicated to the Implementation of Regulatory ... platform for industry, vendors, health authorities, consultants ... work towards a standard method of implementing ...
Breaking Biology News(10 mins):Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3
... Protein Society, the leading international society devoted to furthering ... Protein Science , announce the second annual selection of ... Annual Symposium of The Protein Society (July 27-30, 2014, ... the outstanding contributions for which they are being recognized, ...
... boss loves Atkins. Your sister is gluten-free, and your roommate is ... are. In new research published this month in Cell ... collection of genes that allow an organism to adapt to different ... can cause premature aging and death. Finding a genetic basis ...
... Hospital scientists have discovered a promising new class of ... tuberculosis (TB), a global killer. The drugs increased survival ... drug-resistant strains of TB. St. Jude led the international ... issue of the journal Nature Medicine . ...
Cached Biology News:Scientists find genetic mechanism linking aging to specific diets 2Promising class of antibiotics discovered for treatment of drug-resistant tuberculosis 2
(Date:9/2/2015)...  Neurotech Pharmaceuticals, Inc., announced today the first ... 2 clinical trial of NT-503 Encapsulated Cell Therapy ... choroidal neovascularization secondary to age related macular degeneration ... growth factor (VEGF) receptor protein continuously produced by ... proof-of-concept study will evaluate NT-503 ECT as a ...
(Date:9/2/2015)... ZIONA, Israel , September 2, 2015 /PRNewswire/ ... today announced the intent of the National Institute of Allergy ... of Health (NIH) within the Department of Health and Human ... be held in the United States ... of BiondVax,s universal flu vaccine candidate, Multimeric-001 (M-001), as a ...
(Date:9/2/2015)... ... 02, 2015 , ... The TS5-Q is designed for myriad ... to analysis of athletic performance. Producing high-resolution slow-motion video , the TS5-Q ... process with the naked eye. , Slow motion sequences are commonly seen ...
(Date:9/1/2015)... 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), ... of targeted antiviral therapies, announced today that it will ... Annual Global Investment Conference sponsored by H.C. Wainwright ... The St. Regis Hotel in New York, ... , Chief Executive Officer, will provide an overview of ...
Breaking Biology Technology:Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3ContraVir to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2
... 19 DuPont Chairman and,CEO Charles O. Holliday, Jr., ... will enable the world to keep pace with the ... materials. "Biotechnology is the most powerful tool available ... said. "It holds the promise,to deliver the world more, ...
... Oct. 19 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. (NASDAQ: ... specialty pharmaceutical and,medical device company, today announced ... September 30, 2007 and updated its financial,outlook ... 2007, in conjunction with the,release of Boston ...
... Ltd (SWX: ATLN) today,announced multiple presentations regarding ... the efficacy and safety of Tracleer in,combination ... first 1,500,patients with pulmonary arterial hypertension (PAH) ... And Long-term PAH Disease,Management) Registry. The presentations ...
Cached Biology Technology:Biotechnology Needed to Help Meet Growing Global Needs for Food, Feed, Fuel and Materials, DuPont Chairman & CEO Says at World Food Prize 2Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 2Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 3Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 4Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 5Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 6Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 7Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 8Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 9Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 10Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 11Actelion Announces Multiple Presentations on Tracleer(R) and the REVEAL Registry at CHEST 2007 2Actelion Announces Multiple Presentations on Tracleer(R) and the REVEAL Registry at CHEST 2007 3